Evaluating Community Pharmacy Responses About Levonorgestrel Emergency Contraception by Mystery Caller Characteristics

Tracey A. Wilkinson, Sally Rafie, Porsche D. Clark, Aaron Carroll, Elizabeth Miller

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: Since restrictions on nonprescription sales were removed in 2013, levonorgestrel emergency contraception (EC) should be available without a prescription at pharmacies for consumers of all genders and ages. Using mystery callers, we assessed variations in availability of and access to EC. Methods: In 2015-2016, three sets of mystery callers (two female physicians, two adolescent females, and two adolescent males) each called all licensed retail pharmacies in five U.S. cities using standardized call scripts. Scripts assessed same-day availability and subsequent access to EC for 17-year-olds. Data on various characteristics of calls were collected and compared by caller type. Results: Among the 993 pharmacies called, same-day availability for EC was approximately 80%, with no differences by caller types (p = .34). However, 10.7% of calls made by the adolescent male caller and 8.3% made by the adolescent female caller resulted in incorrectly being told they could not obtain EC based on age, compared to only 1.6% of calls made by the physician (p < .01). Pharmacy staff stated correctly that EC was available over-the-counter more often to adolescent male callers (62.0%) than adolescent females (51.6%) or female physicians (57%) (p < .01). Physicians were more likely to be placed on hold, talk to a pharmacist, or be transferred to a pharmacist (p < .01) than adolescents. Conclusions: Persistent barriers to accessing EC exist for adolescents despite regulatory changes to make EC available over-the-counter, especially for females. Additional work to remove these barriers is needed to assure timely access for those who require effective pregnancy prevention.

Original languageEnglish (US)
JournalJournal of Adolescent Health
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Postcoital Contraception
Levonorgestrel
Pharmacies
Physicians
Pharmacists
Prescriptions
Pregnancy

Keywords

  • Access to health care
  • Adolescent health services
  • Adolescents
  • Contraception
  • Emergency contraception
  • Pharmacy
  • Pregnancy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Public Health, Environmental and Occupational Health
  • Psychiatry and Mental health

Cite this

Evaluating Community Pharmacy Responses About Levonorgestrel Emergency Contraception by Mystery Caller Characteristics. / Wilkinson, Tracey A.; Rafie, Sally; Clark, Porsche D.; Carroll, Aaron; Miller, Elizabeth.

In: Journal of Adolescent Health, 01.01.2018.

Research output: Contribution to journalArticle

@article{a7dbb48f766e49d4b90a48770a22e462,
title = "Evaluating Community Pharmacy Responses About Levonorgestrel Emergency Contraception by Mystery Caller Characteristics",
abstract = "Purpose: Since restrictions on nonprescription sales were removed in 2013, levonorgestrel emergency contraception (EC) should be available without a prescription at pharmacies for consumers of all genders and ages. Using mystery callers, we assessed variations in availability of and access to EC. Methods: In 2015-2016, three sets of mystery callers (two female physicians, two adolescent females, and two adolescent males) each called all licensed retail pharmacies in five U.S. cities using standardized call scripts. Scripts assessed same-day availability and subsequent access to EC for 17-year-olds. Data on various characteristics of calls were collected and compared by caller type. Results: Among the 993 pharmacies called, same-day availability for EC was approximately 80{\%}, with no differences by caller types (p = .34). However, 10.7{\%} of calls made by the adolescent male caller and 8.3{\%} made by the adolescent female caller resulted in incorrectly being told they could not obtain EC based on age, compared to only 1.6{\%} of calls made by the physician (p < .01). Pharmacy staff stated correctly that EC was available over-the-counter more often to adolescent male callers (62.0{\%}) than adolescent females (51.6{\%}) or female physicians (57{\%}) (p < .01). Physicians were more likely to be placed on hold, talk to a pharmacist, or be transferred to a pharmacist (p < .01) than adolescents. Conclusions: Persistent barriers to accessing EC exist for adolescents despite regulatory changes to make EC available over-the-counter, especially for females. Additional work to remove these barriers is needed to assure timely access for those who require effective pregnancy prevention.",
keywords = "Access to health care, Adolescent health services, Adolescents, Contraception, Emergency contraception, Pharmacy, Pregnancy",
author = "Wilkinson, {Tracey A.} and Sally Rafie and Clark, {Porsche D.} and Aaron Carroll and Elizabeth Miller",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jadohealth.2017.11.303",
language = "English (US)",
journal = "Journal of Adolescent Health",
issn = "1054-139X",
publisher = "Elsevier USA",

}

TY - JOUR

T1 - Evaluating Community Pharmacy Responses About Levonorgestrel Emergency Contraception by Mystery Caller Characteristics

AU - Wilkinson, Tracey A.

AU - Rafie, Sally

AU - Clark, Porsche D.

AU - Carroll, Aaron

AU - Miller, Elizabeth

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose: Since restrictions on nonprescription sales were removed in 2013, levonorgestrel emergency contraception (EC) should be available without a prescription at pharmacies for consumers of all genders and ages. Using mystery callers, we assessed variations in availability of and access to EC. Methods: In 2015-2016, three sets of mystery callers (two female physicians, two adolescent females, and two adolescent males) each called all licensed retail pharmacies in five U.S. cities using standardized call scripts. Scripts assessed same-day availability and subsequent access to EC for 17-year-olds. Data on various characteristics of calls were collected and compared by caller type. Results: Among the 993 pharmacies called, same-day availability for EC was approximately 80%, with no differences by caller types (p = .34). However, 10.7% of calls made by the adolescent male caller and 8.3% made by the adolescent female caller resulted in incorrectly being told they could not obtain EC based on age, compared to only 1.6% of calls made by the physician (p < .01). Pharmacy staff stated correctly that EC was available over-the-counter more often to adolescent male callers (62.0%) than adolescent females (51.6%) or female physicians (57%) (p < .01). Physicians were more likely to be placed on hold, talk to a pharmacist, or be transferred to a pharmacist (p < .01) than adolescents. Conclusions: Persistent barriers to accessing EC exist for adolescents despite regulatory changes to make EC available over-the-counter, especially for females. Additional work to remove these barriers is needed to assure timely access for those who require effective pregnancy prevention.

AB - Purpose: Since restrictions on nonprescription sales were removed in 2013, levonorgestrel emergency contraception (EC) should be available without a prescription at pharmacies for consumers of all genders and ages. Using mystery callers, we assessed variations in availability of and access to EC. Methods: In 2015-2016, three sets of mystery callers (two female physicians, two adolescent females, and two adolescent males) each called all licensed retail pharmacies in five U.S. cities using standardized call scripts. Scripts assessed same-day availability and subsequent access to EC for 17-year-olds. Data on various characteristics of calls were collected and compared by caller type. Results: Among the 993 pharmacies called, same-day availability for EC was approximately 80%, with no differences by caller types (p = .34). However, 10.7% of calls made by the adolescent male caller and 8.3% made by the adolescent female caller resulted in incorrectly being told they could not obtain EC based on age, compared to only 1.6% of calls made by the physician (p < .01). Pharmacy staff stated correctly that EC was available over-the-counter more often to adolescent male callers (62.0%) than adolescent females (51.6%) or female physicians (57%) (p < .01). Physicians were more likely to be placed on hold, talk to a pharmacist, or be transferred to a pharmacist (p < .01) than adolescents. Conclusions: Persistent barriers to accessing EC exist for adolescents despite regulatory changes to make EC available over-the-counter, especially for females. Additional work to remove these barriers is needed to assure timely access for those who require effective pregnancy prevention.

KW - Access to health care

KW - Adolescent health services

KW - Adolescents

KW - Contraception

KW - Emergency contraception

KW - Pharmacy

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85042231535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042231535&partnerID=8YFLogxK

U2 - 10.1016/j.jadohealth.2017.11.303

DO - 10.1016/j.jadohealth.2017.11.303

M3 - Article

JO - Journal of Adolescent Health

JF - Journal of Adolescent Health

SN - 1054-139X

ER -